We have used the enzymatic in situ hybridization method to investigate the presence of Epstein-Barr virus (EBV) genome in lymph node tissues from patients with Hodgkin's disease. Also, 11 patients with persistent human immuno-deficiency virus-associated generalized lymphadenopathy as well as seven autopsy cases with no Hodgkin's disease, formed part of these studies.
Introduction
It is known that Epstein-Barr virus (EBV) is clearly associated with endemic Burkitt's lymphoma and lymphomas developed in immunosuppressed patients, as revealed by the presence of EBV genome in the malignant clone of proliferating cells.'-4 By using an EBV terminal-region DNA probe, it has been recently demonstrated that EBV DNA can be detected in approximately 20% of patients with Hodgkin's disease, and that these viral genomes are monoclonal in origin.57 More recently, using polymerase chain reaction (PCR), EBV DNA sequences were detected in 58% ofcases of Hodgkin's disease. 8 Furthermore, in the studies carried out to date using isotopic in situ hybridization methods, the EBV genome has only been encountered in the diagnostic RS cells and variants. 5'8'9 In this paper, we have used the enzymatic in situ hybridization method to study the presence and cell localization of EBV genome in a group of patients with Hodgkin's disease. We identified EBV DNA in the diagnostic cells of seven out of 16 pBR322" containing a 3.1 kb sequence which is reiterated 11-14 times in the EBV genome. The reaction was visualized after incubation with avidin-biotin-peroxidase complex (Enzo) with the use of hydrogen peroxide and aminoethyl carbazole (Sigma). Controls included the omission of the specific viral probe and the replacement of the EBV probe by biotinylated cytomegalovirus DNA (Enzo). Also, an oral hairy leukoplakia lesion from a human immunodeficiency virus (HIV) positive patient as well as the EBV-infected cell line B95-8 were used as positive controls. In addition, several normal lymph nodes derived from different sites at autopsy were obtained from seven patients without Hodgkin's disease and without clinical, serological and histological evidence suggestive of EBV infection. Finally, lymph node tissues from 11 patients with persistent HIV-associated generalized lymphadenopathy, which are part of a previously reported work,'2 were also used (employing the same 'in situ' technology) to test the role of immunosuppression in our results.
Results
An EBV-positive reaction was observed in the nucleus of the Reed-Sternberg cells with a localization, generally, around the nucleoli as well as the nuclear membrane, and exhibiting a round and homogeneous pattern. Hybridization with the EBV probe also showed positive signals in a small proportion of the accompanying non-malignant lymphoid cell population, meanwhile other lymph node cells appeared negative. The majority of Reed-Sternberg cells and variants as well as the non-neoplastic lymphoid cells showed a single positive hybridization site, being few in number. The slides could be interpreted best with high power magnification.
The EBV genome was detected in Reed-Sternberg cells and variants as well as in non-malignant lymphoid cells in seven cases: five cases were nodular sclerosis, one case was mixed cellularity and the last corresponded to lymphocyte predominance (Table I) (Figure 1) . Seven other cases, in which EBV DNA was not found in the Using a colorimetric in situ hybridization method, which has been proved to be useful to detect EBV DNA, '6 we were able to demonstrate the presence of this viral genome in the ReedSternberg cells and variants, in approximately 45% of our cases of Hodgkin's disease. Nevertheless, the most surprising observation was not only the high frequency of cases in which EBV DNA was found in the diagnostic cells, but the demonstration, in close to 85 % ofour cases, of such viral genome also localized in the nucleus of some accompanying small lymphocytes.
Our results lead us to believe that the application of colorimetric methods for in situ detection of hybridized EBV DNA, allows better morphological identification and cell localization of these nucleic acids. It is possible that the background detected by isotopic in situ hybridization, represented by scattered black grains, may not be discernible in some cases due to the small number of viral copies. Furthermore, the positive-stained reaction and the lack of background obtained by our methods also permits a precise detection and cell-type identification of EBV DNA, including those very small nuclear positive signals.
The detection of EBV DNA in the accompanying lymphoid cells in addition to the Reed-Sternberg cells as well as in only half of the cases in the reactive cells, suggests the hypothesis that the immunodeficiency accompanying Hodgkin's disease might favour a latent EBV reactivation with expansion of lymphoid clones harbouring EBV7"7 with the presence of EBV within Reed-Sternberg cells being a non-specific phenomenon. The fact that we have previously found positive EBV signals in the lymph nodes of approximately 75% of immunosuppressed patients with persistent generalized lymphadenopathy'2 might support this hypothesis. In this regard and using a colorimetric in situ hybridization method the presence of EBV in the reactive cells in Hodgkin's disease has also been recently demonstrated.'8"l9 Furthermore, and with the PCR technique, Mashih et al. 20 have recently found a comparable frequency of EBV genome in both hyperplastic lymph nodes and tissues involved by Hodgkin's disease. These findings add support to the hypothesis that EBV infection could be directly related to the pathogenesis of Hodgkin's disease, at least in some cases.
